CurrentRheuma coverage · page 21 of 22

Clinical and Experimental Rheumatology

Briefs 801–840 of 849 CurrentRheuma has covered from this journal, newest publication first

Latest from Clinical and Experimental Rheumatology

All coverage, newest first

Clin Exp Rheumatol4 Mar 2022
Clinical significance of a self-reported familial occurrence of rheumatoid arthritis among patients with recent-onset arthritis: data from the ESPOIR cohort
Cohort studyRA
Clin Exp Rheumatol3 Mar 2022
Confounders contributing to explain the association between sex and disease impact in patients with recent-onset psoriatic arthritis
Cohort studySpondyloarthritis & PsA
Clin Exp Rheumatol2 Mar 2022
Diagnosis of COVID-19 associated arthritis in patients with or without underlying rheumatic and musculoskeletal disease supported by musculoskeletal ultrasound: a case series from three European centres
Cohort studyRA
Clin Exp Rheumatol28 Feb 2022
A one-point increase in the Damage Index for Antiphospholipid Syndrome (DIAPS) predicts mortality in thrombotic antiphospholipid syndrome
Cohort studyLupus & APS
Clin Exp Rheumatol28 Feb 2022
Depression and anxiety in a real-world psoriatic arthritis longitudinal study: should we focus more on patients' perception?
Cohort studySpondyloarthritis & PsA
Clin Exp Rheumatol28 Feb 2022
Real-world data on seropositive rheumatoid arthritis, then and now: ten-year outcomes of 1151 patients diagnosed between 1997 and 2011
Cohort studyRA
Clin Exp Rheumatol24 Feb 2022
Anti-SARS-CoV-2 antibody decay after vaccination and immunogenicity of the booster dose of the BNT162b2 mRNA vaccine in patients with psoriatic arthritis on TNF inhibitors
Cohort studySpondyloarthritis & PsA
Clin Exp Rheumatol24 Feb 2022
Predictors of disease activity in gout: a 12-month analysis of the ATTACk (Achieving improvement in the management of crystal-induced arthritis) multicentre cohort study
Cohort studyGout & crystals
Clin Exp Rheumatol22 Feb 2022
Anti-SSA/Ro positivity and congenital heart block: obstetric and foetal outcome in a cohort of anti-SSA/Ro positive pregnant patients with and without autoimmune diseases
Cohort studyLupus & APS
Clin Exp Rheumatol22 Feb 2022
High incidence of multisystem inflammatory syndrome and other autoimmune diseases after SARS-CoV-2 infection compared to COVID-19 vaccination in children and adolescents in south central Europe
Cohort studyPediatric
Clin Exp Rheumatol22 Feb 2022
Waning humoral immunity of SARS-CoV-2 vaccination in a rheumatoid arthritis cohort and the benefits of a vaccine booster dose
Cohort studyRA
Clin Exp Rheumatol21 Feb 2022
Application of the 2022 ACR/EULAR criteria for microscopic polyangiitis to patients with previously diagnosed microscopic polyangiitis
Cohort studyVasculitis & PMR
Clin Exp Rheumatol18 Feb 2022
Interstitial lung disease in adult patients with anti-NXP2 antibody positivity: a multicentre 18-month follow-up study
Cohort studyMyositis
Clin Exp Rheumatol18 Feb 2022
Medical cannabis use by rheumatology patients in routine clinical care: results from The Ontario Best Practices Research Initiative
Cross-sectional studyAcross diseases
Clin Exp Rheumatol17 Feb 2022
Use of Janus kinase inhibitors in dermatomyositis: a systematic literature review
Research articleMyositis
Clin Exp Rheumatol12 Feb 2022
The effect of COVID-19 pandemic on idiopathic inflammatory myositis patients: a single centre experience
Cross-sectional studyMyositis
Clin Exp Rheumatol8 Feb 2022
Association of the serum IgG glycosylation with disease activity of anti-transcription intermediary factor 1 gamma positive dermatomyositis
Cross-sectional studyMyositis
Clin Exp Rheumatol8 Feb 2022
Response to netakimab in radiographic axial spondyloarthritis patients with different baseline C-reactive protein, sacroiliitis evaluated by MRI and peripheral joint involvement status: a post-hoc analysis of the ASTERA study
Secondary analysisSpondyloarthritis & PsA
Clin Exp Rheumatol6 Feb 2022
Persistence of remission after lengthening of golimumab in inflammatory joint diseases
Cohort studySpondyloarthritis & PsA
Clin Exp Rheumatol28 Jan 2022
Efficacy of secukinumab on dactylitis in patients with active psoriatic arthritis from the FUTURE 5 study
Secondary analysisSpondyloarthritis & PsA
Clin Exp Rheumatol23 Jan 2022
Can biomarkers predict successful tapering of conventional disease-modifying therapy in rheumatoid arthritis patients in stable remission?
Cohort studyRA
Clin Exp Rheumatol21 Jan 2022
Effectiveness of non-medical switch from adalimumab bio-originator to SB5 biosimilar and from ABP501 adalimumab biosimilar to SB5 biosimilar in patients with chronic inflammatory arthropathies: a monocentric observational study
Cohort studyAcross diseases
Clin Exp Rheumatol20 Jan 2022
Differentiating patients with psoriasis from psoriatic arthritis using collagen biomarkers
Cross-sectional studySpondyloarthritis & PsA
Clin Exp Rheumatol19 Jan 2022
Clinical characteristics of 1020 childhood-onset systemic lupus erythematosus: data from a health centre in China
Cohort studyPediatric
Clin Exp Rheumatol16 Jan 2022
Decreased perforin-producing B cells correlate with systemic lupus erythematosus
Mechanistic studyLupus & APS
Clin Exp Rheumatol15 Jan 2022
Reactogenicity, safety and disease flares following BNT162b2 mRNA COVID-19 vaccine in patients with chronic immune-inflammatory arthritis treated with biological and targeted synthetic disease-modifying anti-rheumatic drugs
Cohort studyAcross diseases
Clin Exp Rheumatol13 Jan 2022
Primary antiphospholipid syndrome as a cause of impaired left ventricular diastolic function: experience from a Serbian cohort
Cross-sectional studyLupus & APS
Clin Exp Rheumatol12 Jan 2022
Serum leptin concentration is associated with the attainment of clinical outcomes in patients with axial spondyloarthritis treated with TNF inhibitors
Cohort studySpondyloarthritis & PsA
Clin Exp Rheumatol10 Jan 2022
Open-label, prospective, phase II descriptive pilot trial of belimumab therapy for refractory and/or non-criteria manifestations of antiphospholipid syndrome: study protocol
Trial designLupus & APS
Clin Exp Rheumatol8 Jan 2022
Risk of malignant melanoma and non-melanoma skin cancer in rheumatoid arthritis patients initiating methotrexate versus hydroxychloroquine: a cohort study
Cohort studyRA
Clin Exp Rheumatol5 Jan 2022
High prevalence of necrotising myopathy pattern in muscle biopsies of patients with anti-Jo-1 antisynthetase syndrome
Cross-sectional studyMyositis
Clin Exp Rheumatol5 Jan 2022
Impact of psoriasis remains important in psoriatic arthritis patients with low musculoskeletal disease activity
Cohort studySpondyloarthritis & PsA
Clin Exp Rheumatol26 Dec 2021
Alpha-Klotho protein in systemic lupus erythematosus
Cross-sectional studyLupus & APS
Clin Exp Rheumatol23 Dec 2021
Haemoglobin changes and disease activity in Japanese patients with rheumatoid arthritis treated with sarilumab
Secondary analysisRA
Clin Exp Rheumatol18 Dec 2021
From first symptoms to diagnosis of systemic lupus erythematosus: mapping the journey of patients in an observational study
Cohort studyLupus & APS
Clin Exp Rheumatol16 Dec 2021
Association of circulating lymphocyte subsets with response to IL17i and TNFi in axial spondyloarthritis
Cohort studySpondyloarthritis & PsA
Clin Exp Rheumatol13 Dec 2021
New onset and flare of rheumatic diseases following COVID-19 vaccination are mild and respond well to treatment: 9-month follow-up data from a single centre cohort
Cohort studyRA
Clin Exp Rheumatol12 Dec 2021
Disease activity in patients with rheumatoid arthritis increases serum levels of apolipoprotein C-III
Cross-sectional studyRA
Clin Exp Rheumatol4 Dec 2021
Clinical and laboratory factors associated with the bamboo spine in patients with axial spondyloarthritis: are there clues for the bamboo spine?
Cross-sectional studySpondyloarthritis & PsA
Clin Exp Rheumatol29 Nov 2021
Improvement in hepatic fibrosis estimated by Fibrosis-4 index in pegloticase treated chronic refractory gout patients
Secondary analysisGout & crystals

All 849 Briefs in ExploreShowing Briefs 801–840 of 849, newest first